Rockwell Medical Enters New And Expanded Distribution Agreement With BioNuclear And Atlantic Medical International
Rockwell Medical Enters New And Expanded Distribution Agreement With BioNuclear And Atlantic Medical International
羅克韋爾醫療與Bionuclear和Atlantic Medical International簽訂新的和擴大的分銷協議
In the aggregate, these agreements are expected to generate approximately $1 million in annual revenues for the Company. The amended distribution agreement between Rockwell Medical and AMI expands the list of hemodialysis products that AMI is purchasing from the Company, includes purchasing commitments, and generates a profit margin consistent with Rockwell Medical's gross margin guidance for 2024.
總體而言，這些協議預計將爲公司帶來約100萬美元的年收入。經修訂的羅克韋爾醫療與AMI之間的分銷協議擴大了AMI從公司購買的血液透析產品的清單，包括購買承諾，併產生了與羅克韋爾醫療2024年毛利率預期一致的利潤率。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。